152 related articles for article (PubMed ID: 38064450)
1. Smoking and pre-existing co-morbidities as risk factors for developing severity of COVID-19 infection: Evidence from a field hospital in a rural area of Bangladesh.
Islam R; Ahmed S; Chakma SK; Mahmud T; Al Mamun A; Islam Z; Islam MM
PLoS One; 2023; 18(12):e0295040. PubMed ID: 38064450
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K
Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903
[TBL] [Abstract][Full Text] [Related]
3. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
Ge E; Li Y; Wu S; Candido E; Wei X
PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.
Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G
Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909
[TBL] [Abstract][Full Text] [Related]
5. Detrimental effect of diabetes and hypertension on the severity and mortality of COVID-19 infection: A multi-center case-control study from India.
Jayaswal SK; Singh S; Malik PS; Venigalla SK; Gupta P; Samaga SN; Hota RN; Bhatia SS; Gupta I
Diabetes Metab Syndr; 2021; 15(5):102248. PubMed ID: 34412000
[TBL] [Abstract][Full Text] [Related]
6. Associations of Self-Reported Cigarette Smoking with Chronic Obstructive Pulmonary Disease and Co-Morbid Chronic Conditions in the United States.
Cunningham TJ; Ford ES; Rolle IV; Wheaton AG; Croft JB
COPD; 2015 Jun; 12(3):276-86. PubMed ID: 25207639
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and impact of diabetes and cardiovascular disease on clinical outcome among patients with COVID-19 in Bangladesh.
Sharif N; Ahmed SN; Opu RR; Tani MR; Dewan D; Daullah MU; Shanto RI; Parvez AK; Talukder AA; Dey SK
Diabetes Metab Syndr; 2021; 15(3):1009-1016. PubMed ID: 33993046
[TBL] [Abstract][Full Text] [Related]
8. Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study.
Maggi P; Santoro CR; Nofri M; Ricci E; De Gennaro N; Bellacosa C; Schiaroli E; Orofino G; Menzaghi B; Di Biagio A; Squillace N; Francisci D; Vichi F; Molteni C; Bonfanti P; Gaeta GB; De Socio GV
BMC Infect Dis; 2019 Jun; 19(1):555. PubMed ID: 31238916
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients.
Dorjee K; Kim H; Bonomo E; Dolma R
PLoS One; 2020; 15(12):e0243191. PubMed ID: 33284825
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and impact of comorbidities on disease prognosis among patients with COVID-19 in Bangladesh: A nationwide study amid the second wave.
Sharif N; Opu RR; Ahmed SN; Sarkar MK; Jaheen R; Daullah MU; Khan S; Mubin M; Rahman H; Islam F; Haque N; Islam S; Khan FB; Haque N; Ayman U; Shohael AM; Dey SK; Talukder AA
Diabetes Metab Syndr; 2021; 15(4):102148. PubMed ID: 34186349
[TBL] [Abstract][Full Text] [Related]
11. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK.
Bloom CI; Drake TM; Docherty AB; Lipworth BJ; Johnston SL; Nguyen-Van-Tam JS; Carson G; Dunning J; Harrison EM; Baillie JK; Semple MG; Cullinan P; Openshaw PJM;
Lancet Respir Med; 2021 Jul; 9(7):699-711. PubMed ID: 33676593
[TBL] [Abstract][Full Text] [Related]
12. Depression and anxiety among individuals with medical conditions during the COVID-19 pandemic: Findings from a nationwide survey in Bangladesh.
Tasnim R; Sujan MSH; Islam MS; Ferdous MZ; Hasan MM; Koly KN; Potenza MN
Acta Psychol (Amst); 2021 Oct; 220():103426. PubMed ID: 34619554
[TBL] [Abstract][Full Text] [Related]
13. Effect modification by age of the association between obstructive lung diseases, smoking, and COVID-19 severity.
Moschovis PP; Lu M; Hayden D; Yonker LM; Lombay J; Taveras E; Arauz Boudreau A; Triant VA; Foulkes AS; Bassett I; Hibberd PL; Kinane TB
BMJ Open Respir Res; 2021 Nov; 8(1):. PubMed ID: 34740944
[TBL] [Abstract][Full Text] [Related]
14. Obesity, diabetes, hypertension and severe outcomes among inpatients with coronavirus disease 2019: a nationwide study.
Bailly L; Fabre R; Courjon J; Carles M; Dellamonica J; Pradier C
Clin Microbiol Infect; 2022 Jan; 28(1):114-123. PubMed ID: 34537362
[TBL] [Abstract][Full Text] [Related]
15. Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness.
Ferastraoaru D; Hudes G; Jerschow E; Jariwala S; Karagic M; de Vos G; Rosenstreich D; Ramesh M
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1152-1162.e3. PubMed ID: 33495097
[TBL] [Abstract][Full Text] [Related]
16. Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis.
Li X; Zhong X; Wang Y; Zeng X; Luo T; Liu Q
PLoS One; 2021; 16(5):e0250602. PubMed ID: 33939733
[TBL] [Abstract][Full Text] [Related]
17. Chronic obstructive pulmonary disease and asthma-patient characteristics and health impairment.
Pleasants RA; Ohar JA; Croft JB; Liu Y; Kraft M; Mannino DM; Donohue JF; Herrick HL
COPD; 2014 Jun; 11(3):256-66. PubMed ID: 24152212
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease is associated with COPD severity and reduced functional status and quality of life.
Black-Shinn JL; Kinney GL; Wise AL; Regan EA; Make B; Krantz MJ; Barr RG; Murphy JR; Lynch D; Silverman EK; Crapo JD; Hokanson JE;
COPD; 2014 Sep; 11(5):546-51. PubMed ID: 24831864
[TBL] [Abstract][Full Text] [Related]
19. The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients.
Shin EK; Choi HY; Hayes N
Epidemiol Health; 2021; 43():e2021035. PubMed ID: 33971700
[TBL] [Abstract][Full Text] [Related]
20. Quality of life of COVID-19 recovered patients: a 1-year follow-up study from Bangladesh.
Hawlader MDH; Rashid MU; Khan MAS; Liza MM; Akter S; Hossain MA; Rahman T; Barsha SY; Shifat AA; Hossian M; Mishu TZ; Sagar SK; Manna RM; Ahmed N; Debu SSSD; Chowdhury I; Sabed S; Ahmed M; Borsha SA; Al Zafar F; Hyder S; Enam A; Babul H; Nur N; Haque MMA; Roy S; Tanvir Hassan KM; Rahman ML; Nabi MH; Dalal K
Infect Dis Poverty; 2023 Aug; 12(1):79. PubMed ID: 37626363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
